Organon & (OGN) Tmuɣli n wazal
Organ & Co.
Ṛṛbem n lḥedd$13.73Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel+0.07%
Asnulfu n AI: OGN
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Organon & Co. is a global pharmaceutical company operating in the women’s health, biosimilars, and popular brands segments. The company develops contraceptives and fertility treatments, immunology products and oncology drugs, as well as a broad range of cardiovascular, respiratory, dermatological, and non-opioid therapy medications.
